Residency · Philadelphia, PA
Sponsored by Tower Health
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
The New England journal of medicine · 2023 · 1,032 citations · Ayman Samkari
Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.
Journal of the American Academy of Dermatology · 2024 · 210 citations · Anne Singh
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial.
The Lancet. Oncology · 2022 · 688 citations · Ayman Samkari
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
MMWR. Morbidity and mortality weekly report · 2023 · 288 citations · Sarah Long
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
MMWR. Morbidity and mortality weekly report · 2023 · 275 citations · Sarah Long
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
MMWR. Morbidity and mortality weekly report · 2023 · 283 citations · Sarah Long
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet (London, England) · 2024 · 288 citations · Ayman Samkari
Guidelines of care for the management of atopic dermatitis in adults with topical therapies.
Journal of the American Academy of Dermatology · 2023 · 164 citations · Anne Singh